Toward A New Business Model for Biosimilars
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.931
https://www.valueinhealthjournal.com/article/S1098-3015(16)32297-5/fulltext
Title :
Toward A New Business Model for Biosimilars
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32297-5&doi=10.1016/j.jval.2016.09.931
First page :
A507
Section Title :
Health Care Use & Policy Studies
Open access? :
No
Section Order :
876